Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pneumonia, Viral

• Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BAL
• Cromolyn Sodium for Treatment of COVID-19 Pneumonia
• Yinhu Qingwen Granule in the Treatment of Viral Pneumonia
• Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.
• Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia
• Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19
• Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial
• Antiviral Drugs on the Treatment of SARS-CoV-2
• Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19
• Nebulized Heparin for the Treatment of COVID-19
• Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
• Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)
• Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
• Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19
• Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
• Toclizumam Versus Dexamethasone in Severe Covid-19 Cases
• Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
• Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement
• COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
• Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS
• High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy
• Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
• Silymarin in COVID-19 Pneumonia
• Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
• Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
• Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19
• Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
• Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora
• COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1
• A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
• Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
• Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
• Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
• Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
• Checkpoint Blockade in COVID-19 Pandemic
• COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
• Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
• Colchicine Counteracting Inflammation in COVID-19 Pneumonia
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection
• Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
• PTH - Preemptive Treatment for Herpesviridae
• Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
• Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu